Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis
- PMID: 10987283
Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis
Abstract
The mutational inactivation of a tumor suppressor gene, adenomatous polyposis coli (APC), results in the accumulation of cytoplasmic beta-catenin protein and the activation of T-cell factor (TCF)/lymphoid enhancer factor transcriptional factors. A colorectal carcinoma cell line, DLD-1, was engineered to suppress transactivation by the TCF4/beta-catenin complex in a dominant-negative manner under the strict control of the tetracycline regulatory system. A large-scale comparison of the expression profiles, using two-color fluorescence hybridization of cDNA microarray, led to the identification of MDR1 as a target gene of the TCF4/beta-catenin complex. Luciferase reporter and gel retardation assays revealed the TCF4/beta-catenin responsive elements in the promoter of the human MDR1 gene. Corresponding to the accumulation of beta-catenin, expression of the MDR1 gene product was steadily up-regulated in adenomas and adenocarcinomas of 10 patients with familial adenomatous polyposis. In combination with cell proliferative activities of c-myc and cyclin D1, MDR1 may initiate colorectal tumorigenesis by suppressing cell death pathways programmed in intestinal epithelial cells.
Similar articles
-
Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation.Cancer Res. 2001 Mar 15;61(6):2751-8. Cancer Res. 2001. PMID: 11289158
-
Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.Cancer Res. 2002 Oct 15;62(20):5651-6. Cancer Res. 2002. PMID: 12384519
-
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.Nature. 1999 Apr 1;398(6726):422-6. doi: 10.1038/18884. Nature. 1999. PMID: 10201372
-
[Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].Med Klin (Munich). 2003 Dec 15;98(12):776-82. doi: 10.1007/s00063-003-1325-2. Med Klin (Munich). 2003. PMID: 14685680 Review. German.
-
[From gene to disease; the APC gene and familial adenomatous polyposis coli].Ned Tijdschr Geneeskd. 2000 Oct 14;144(42):2007-9. Ned Tijdschr Geneeskd. 2000. PMID: 11072519 Review. Dutch.
Cited by
-
Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways.Br J Cancer. 2007 Mar 26;96(6):918-27. doi: 10.1038/sj.bjc.6603641. Epub 2007 Mar 6. Br J Cancer. 2007. PMID: 17342096 Free PMC article.
-
Cell adhesion system and human cancer morphogenesis.Cancer Sci. 2003 Jul;94(7):575-81. doi: 10.1111/j.1349-7006.2003.tb01485.x. Cancer Sci. 2003. PMID: 12841864 Free PMC article. Review.
-
Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines.Evid Based Complement Alternat Med. 2018 Aug 12;2018:3412074. doi: 10.1155/2018/3412074. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30158992 Free PMC article. Review.
-
Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.J Exp Clin Cancer Res. 2019 Jun 7;38(1):243. doi: 10.1186/s13046-019-1231-y. J Exp Clin Cancer Res. 2019. PMID: 31174562 Free PMC article.
-
From competency to dormancy: a 3D model to study cancer cells and drug responsiveness.J Transl Med. 2016 Feb 4;14:38. doi: 10.1186/s12967-016-0798-8. J Transl Med. 2016. PMID: 26847768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous